Prophylactic anticoagulants for people hospitalised with COVID‐19

BACKGROUND: Coronavirus disease 2019 (COVID‐19) is a serious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The primary manifestation is respiratory insufficiency that can also be related to diffuse pulmonary microthrombosis in people with COVID‐19. This disease also...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Flumignan, Ronald LG, Tinôco, Jéssica Dantas de Sá, Pascoal, Patricia IF, Areias, Libnah L, Cossi, Marcelly S, Fernandes, Maria ICD, Costa, Isabelle KF, Souza, Larissa, Matar, Charbel F, Tendal, Britta, Trevisani, Virginia FM, Atallah, Álvaro N, Nakano, Luis CU
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2020
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8166900/
https://ncbi.nlm.nih.gov/pubmed/33502773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013739
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados